Researchers take to space to study cancer drug delivery; Purdue, U.S. Army team up for aneurysm nanotreatment;

 @DamianFierce: Perhaps you can have too much of a good thing. Penn researchers say too many nanocarriers render treatments ineffective. Story | Follow @DamianFierce

> One research team is conducting research on microscale drug delivery for cancer APIs in an uncommon laboratory: the International Space Station. News

> Scientists at the University of Washington and Cornell University have designed three-dimensional, fully functional multivascular networks, allowing for in vitro studies of how drugs interact with vascular systems. Report

> Flexion is celebrating positive Phase IIb results for an intra-articularly delivered osteoarthritis drug, the blockbuster hopeful FX-005. Article

> Purdue and the U.S. Army are working together on nanotechnology-enhanced stents that could treat aneurysms. Story